139 related articles for article (PubMed ID: 24380836)
1. Up-regulation of nucleotide excision repair in mouse lung and liver following chronic exposure to aflatoxin B₁ and its dependence on p53 genotype.
Mulder JE; Bondy GS; Mehta R; Massey TE
Toxicol Appl Pharmacol; 2014 Mar; 275(2):96-103. PubMed ID: 24380836
[TBL] [Abstract][Full Text] [Related]
2. The impact of chronic Aflatoxin B1 exposure and p53 genotype on base excision repair in mouse lung and liver.
Mulder JE; Bondy GS; Mehta R; Massey TE
Mutat Res; 2015 Mar; 773():63-8. PubMed ID: 25847422
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat.
Bedard LL; Alessi M; Davey S; Massey TE
Cancer Res; 2005 Feb; 65(4):1265-70. PubMed ID: 15735011
[TBL] [Abstract][Full Text] [Related]
4. Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo.
Alekseyev YO; Hamm ML; Essigmann JM
Carcinogenesis; 2004 Jun; 25(6):1045-51. PubMed ID: 14742311
[TBL] [Abstract][Full Text] [Related]
5. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
[TBL] [Abstract][Full Text] [Related]
6. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
[TBL] [Abstract][Full Text] [Related]
7. Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts.
Guillermo-Lagae R; Deep G; Ting H; Agarwal C; Agarwal R
Oncotarget; 2015 Nov; 6(37):39594-606. PubMed ID: 26447614
[TBL] [Abstract][Full Text] [Related]
8. In vivo treatment with aflatoxin B1 increases DNA oxidation, base excision repair activity and 8-oxoguanine DNA glycosylase 1 levels in mouse lung.
Guindon-Kezis KA; Mulder JE; Massey TE
Toxicology; 2014 Jul; 321():21-6. PubMed ID: 24675474
[TBL] [Abstract][Full Text] [Related]
9. Aflatoxin B1-induced DNA damage and its repair.
Bedard LL; Massey TE
Cancer Lett; 2006 Sep; 241(2):174-83. PubMed ID: 16458422
[TBL] [Abstract][Full Text] [Related]
10. In vivo treatment with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces organ-specific alterations in in vitro repair of DNA pyridyloxobutylation.
Brown PJ; Massey TE
Mutat Res; 2009 Apr; 663(1-2):15-21. PubMed ID: 19152800
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of DNA damage-induced p53 expression by arsenic: a possible mechanism for arsenic co-carcinogenesis.
Shen S; Lee J; Weinfeld M; Le XC
Mol Carcinog; 2008 Jul; 47(7):508-18. PubMed ID: 18085531
[TBL] [Abstract][Full Text] [Related]
12. Benzo[a]pyrene (BP) DNA adduct formation in DNA repair-deficient p53 haploinsufficient [Xpa(-/-)p53(+/-)] and wild-type mice fed BP and BP plus chlorophyllin for 28 days.
John K; Pratt MM; Beland FA; Churchwell MI; McMullen G; Olivero OA; Pogribny IP; Poirier MC
Carcinogenesis; 2012 Nov; 33(11):2236-41. PubMed ID: 22828138
[TBL] [Abstract][Full Text] [Related]
13. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract][Full Text] [Related]
14. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells.
Wani MA; Zhu Q; El-Mahdy M; Venkatachalam S; Wani AA
Cancer Res; 2000 Apr; 60(8):2273-80. PubMed ID: 10786695
[TBL] [Abstract][Full Text] [Related]
15. Benzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.
van Kesteren PC; Zwart PE; Schaap MM; Pronk TE; van Herwijnen MH; Kleinjans JC; Bokkers BG; Godschalk RW; Zeilmaker MJ; van Steeg H; Luijten M
Arch Toxicol; 2013 Mar; 87(3):505-15. PubMed ID: 23052197
[TBL] [Abstract][Full Text] [Related]
16. Failure of catalase to protect against aflatoxin B1-induced mouse lung tumorigenicity.
Guindon KA; Foley JF; Maronpot RR; Massey TE
Toxicol Appl Pharmacol; 2008 Mar; 227(2):179-83. PubMed ID: 18155117
[TBL] [Abstract][Full Text] [Related]
17. Excision repair of aflatoxin B1-DNA adducts in human fibroblasts.
Leadon SA; Tyrrell RM; Cerutti PA
Cancer Res; 1981 Dec; 41(12 Pt 1):5125-9. PubMed ID: 6796265
[TBL] [Abstract][Full Text] [Related]
18. Finding transcriptomics biomarkers for in vivo identification of (non-)genotoxic carcinogens using wild-type and Xpa/p53 mutant mouse models.
Jonker MJ; Bruning O; van Iterson M; Schaap MM; van der Hoeven TV; Vrieling H; Beems RB; de Vries A; van Steeg H; Breit TM; Luijten M
Carcinogenesis; 2009 Oct; 30(10):1805-12. PubMed ID: 19696161
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
Barckhausen C; Roos WP; Naumann SC; Kaina B
Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
[TBL] [Abstract][Full Text] [Related]
20. Delay of DNA-adduct repair and severe toxicity in xeroderma pigmentosum group A gene (XPA) deficient mice treated with 2-amino-1-methyl-6-phenyl-imidazo [4,5-b] pyridine (PhIP).
Imaida K; Ogawa K; Takahashi S; Ito T; Yamaguchi T; Totsuka Y; Wakabayashi K; Tanaka K; Ito N; Shirai T
Cancer Lett; 2000 Mar; 150(1):63-9. PubMed ID: 10755388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
